Premium
Indian pharmaceuticals companies, which are striving hard to maintain its growth and facing greater regulatory pressure in their key market of the US, could face fresh challenges as the government plans to bring more medicines under its price control regime. Some drugs used to treat life-threatening diseases like cancer, diabetes and ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
